Blood Glucose Test Strip Market - Latest Advancement And Analysis (2024-2032)

Blood Glucose Test Strip Market Synopsis:

Blood Glucose Test Strip Market Size Was Valued at USD 18.14 Billion in 2023, and is Projected to Reach USD 33.80 Billion by 2032, Growing at a CAGR of 7.43% From 2024-2032.

The Blood glucose test strip market includes the industry deals with production and distribution of disposable test strips used in combination with glucose meters. They are used in determining glucose level in the body targeting diabetic persons and such other complications. The test strips are however designed to work with a small sample of blood and the result as indicated on a glucose meter. We have found blood glucose test strips to be an essential piece of diabetic care equipment, being used to test glucose levels from the comfort of one’s home.

The research indicates that the demand of blood glucose test strip has been escalating gradually over the last decade mainly due to the global rise in number of diabetes mellitus patients and global concern towards the periodic monitoring of blood glucose level. Market is mainly influenced by technology in that there has been rapid growth in the glucose monitoring devices which is translating to efficient, accurate and easier Blood Glucose meters. Other driver that has also fa acted in the increasing usage of test strips include home based blood glucose monitoring systems. More so, trends such as the rising incidence of diabetes mainly diabetes type one and two, and the chances of population aging are factors that are anticipated to push the market forward even further.

It is categorized by various product forms, namely one-time use and reusable strip separating, as well as testing forms including electrochemical and photometric. Regionally the market is divided into North America, Europe, and Asia Pacific which control the market. But today’s markets of Asia, Latin America, and Africa show tendency of fast development because of growing demand for, and access to, health care services. There is also emergence of strips which need lesser quantity of blood and deliver results more quickly, which is a pleasant to the market’s continuing trend of increased demand for easier and quicker use of glucose. Of particular importance is the fact that as healthcare policies change and a move towards personalized medicine is made, the BGMT market is expected to grow greatly.

Blood Glucose Test Strip Market Trend Analysis:

Increasing Adoption of Smart Glucose Meters

• A key market trend now prevalent in the blood glucose test strip market is the increased demand for the smart glucose meters that have enhanced features such as Bluetooth, data storage and further connection with Smartphone. These smart meters help them monitor their blood glucose levels and share data with physicians on those levels and recommended exercises regimens. Based on this, a string for blood glucose test strips that will be used with such devices will be issued due to the popularity of these technologies among diabetic patients due to their enhanced capabilities to check and control the disease. This change is likely to take place gradually as the diabetic population weans itself off the traditional style of glucose meter uses and towards the smart glucose meters.
• Moreover, the CGM systems are tucked into rise as an emerging trend on the market. Cgm systems deliver continuous data of glucose level hence minimizing the use of finger stick test. This changing technology poses a major shift in how blood glucose can be tested despite the fact that test strips will remain in market since some patients prefer using the strips to check their blood glucose levels.

Rising Diabetes Prevalence in Emerging Markets

• The increasing incidence of the disease is one of the greatest potentials in the market for blood glucose test strips, especially in developing countries like India, China and Latin America. These regions are witnessing a dramatically rising incidence of Type 2 diabetes, largely because of lifestyle conditions, including urbanization, reduced physical activity, and altering diets that are typical of the contemporary world. Since the number of Diabetes patients continues to increase, the need for products such as test strips used in glucose monitoring also increases. Healthcare systems and governments are also spending in the health facilities and this is going a long way in increasing the awareness on the effects of diabetes and necessity of glucose test. The availability of healthcare as well as the expanding prevalence of diabetes is considered as the major clue to the expansion of market in these areas.

Blood Glucose Test Strip Market Segment Analysis:

Blood Glucose Test Strip Market is Segmented on the basis of Type, Application, End User, And Region

By Type, Glucose Dehydrogenase (GDH) segment is expected to dominate the market during the forecast period

• Among the several segments involved in the blood glucose test strip market the Glucose Dehydrogenase (GDH) segment is expected to be the market leader during the given time period due to factors such factors as accuracy and reliability levels, and applicability to small blood samples. A technique that comes with GDH-based test strips is particularly preferred due to their accurate ability in determining blood glucose levels, especially in patients with fluctuating or even high/low blood glucose level or those that will be checked regularly. The increase in the use of the GDH-based technology in glucose meters is due to this fact that it produces better results in a short time and requires less blood than most enzymatic procedures. Moreover, GDH-based test strips are more resistant to interference from oxygen and other chemicals which also will help increase its use. This segment’s domination is further bolstered by new developments in GDH technology, resulting in better features such as better, faster and easier to use than before because of the rising need for easy-to-use diabetes testing equipment.

By Application, Type 1 Diabetes segment expected to held the largest share

• Based on the application, the Type 1 Diabetes segment will dominate the blood glucose test strip market throughout the forecast period as people with this disease are required to maintain strict blood glucose levels for the rest of their lives. People with type I diabetes need several times a day checking of blood glucose, in order to adjust the dosage of insulin and avoid hyperglycaemia and hypoglycaemia. For such reasons, as the global incidence of Type 1 diabetes increases, requirements for accurate and effective glucose monitoring equipment like test strips also grows. Type 1 diabetes care integrated with personalized care and sophisticated diabetes management also adds to the usage of blood glucose test strips for Type 1. The market dominance in this segment is also boosted by the expansion of health care coverage, and better understanding of diabetes so as to enable people with Type 1 diabetes prepare to monitor blood sugar levels effectively.

Blood Glucose Test Strip Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• In 2023, • By 2023, the global market for blood glucose test strips maintained the status it achieved in 2018 with North America at the fore front mainly driven by the United States’ contribution towards the market share. It captures a large market share of the global market mainly because of high incidence of diabetes, well-developed healthcare system, and the use of DM devices. North American market by 2023 captured roughly the half of total volume of the global blood glucose test strip market. High involvement of leading contenders, greater proportion of health care spending and mounting concern towards chronic diseases are the distinguishing features of the region.

Active Key Players in the Blood Glucose Test Strip Market:

• A. Menarini Diagnostics (Italy)
• Abbott Laboratories (USA)
• Arkray (Japan)
• Ascensia Diabetes Care (Switzerland)
• Bayer Healthcare (Germany)
• BD (Becton, Dickinson and Company) (USA)
• Dexcom (USA)
• Johnson & Johnson (USA)
• LifeScan (USA)
• Medtronic (Ireland)
• Nova Biomedical (USA)
• Omron Healthcare (Japan)
• Roche (Switzerland)
• Trividia Health (USA)
• Ypsomed (Switzerland)
• Other Active Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Blood Glucose Test Strip Market by Type
 4.1 Blood Glucose Test Strip Market Snapshot and Growth Engine
 4.2 Blood Glucose Test Strip Market Overview
 4.3 Glucose Dehydrogenase (GDH)
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Glucose Dehydrogenase (GDH): Geographic Segmentation Analysis
 4.4 Glucose Oxidase (GOD)
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Glucose Oxidase (GOD): Geographic Segmentation Analysis

Chapter 5: Blood Glucose Test Strip Market by Application
 5.1 Blood Glucose Test Strip Market Snapshot and Growth Engine
 5.2 Blood Glucose Test Strip Market Overview
 5.3 Type 1 Diabetes
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Type 1 Diabetes: Geographic Segmentation Analysis
 5.4 Type 2 Diabetes
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Type 2 Diabetes: Geographic Segmentation Analysis
 5.5 Gestational Diabetes
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Gestational Diabetes: Geographic Segmentation Analysis
 5.6 Pre-Diabetes
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Pre-Diabetes: Geographic Segmentation Analysis

Chapter 6: Blood Glucose Test Strip Market by End User
 6.1 Blood Glucose Test Strip Market Snapshot and Growth Engine
 6.2 Blood Glucose Test Strip Market Overview
 6.3 Individuals
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Individuals: Geographic Segmentation Analysis
 6.4 Hospitals & Clinics
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Hospitals & Clinics: Geographic Segmentation Analysis
 6.5 Others
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Others: Geographic Segmentation Analysis

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Benchmarking
  7.1.2 Blood Glucose Test Strip Market Share by Manufacturer (2023)
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 Mergers and Acquisitions  
 7.2 A. MENARINI DIAGNOSTICS (ITALY)
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Role of the Company in the Market
  7.2.5 Sustainability and Social Responsibility
  7.2.6 Operating Business Segments
  7.2.7 Product Portfolio
  7.2.8 Business Performance
  7.2.9 Key Strategic Moves and Recent Developments
  7.2.10 SWOT Analysis
 7.3 ABBOTT LABORATORIES (USA)
 7.4 ARKRAY (JAPAN)
 7.5 ASCENSIA DIABETES CARE (SWITZERLAND)
 7.6 BAYER HEALTHCARE (GERMANY)
 7.7 BD (BECTON
 7.8 DICKINSON AND COMPANY) (USA)
 7.9 DEXCOM (USA)
 7.10 JOHNSON & JOHNSON (USA)
 7.11 LIFESCAN (USA)
 7.12 MEDTRONIC (IRELAND)
 7.13 NOVA BIOMEDICAL (USA)
 7.14 OMRON HEALTHCARE (JAPAN)
 7.15 ROCHE (SWITZERLAND)
 7.16 TRIVIDIA HEALTH (USA)
 7.17 YPSOMED (SWITZERLAND)
 7.18 OTHER ACTIVE PLAYERS

Chapter 8: Global Blood Glucose Test Strip Market By Region
 8.1 Overview
 8.2. North America Blood Glucose Test Strip Market
  8.2.1 Key Market Trends, Growth Factors and Opportunities
  8.2.2 Top Key Companies
  8.2.3 Historic and Forecasted Market Size by Segments
  8.2.4 Historic and Forecasted Market Size By Type
  8.2.4.1 Glucose Dehydrogenase (GDH)
  8.2.4.2 Glucose Oxidase (GOD)
  8.2.5 Historic and Forecasted Market Size By Application
  8.2.5.1 Type 1 Diabetes
  8.2.5.2 Type 2 Diabetes
  8.2.5.3 Gestational Diabetes
  8.2.5.4 Pre-Diabetes
  8.2.6 Historic and Forecasted Market Size By End User
  8.2.6.1 Individuals
  8.2.6.2 Hospitals & Clinics
  8.2.6.3 Others
  8.2.7 Historic and Forecast Market Size by Country
  8.2.7.1 US
  8.2.7.2 Canada
  8.2.7.3 Mexico
 8.3. Eastern Europe Blood Glucose Test Strip Market
  8.3.1 Key Market Trends, Growth Factors and Opportunities
  8.3.2 Top Key Companies
  8.3.3 Historic and Forecasted Market Size by Segments
  8.3.4 Historic and Forecasted Market Size By Type
  8.3.4.1 Glucose Dehydrogenase (GDH)
  8.3.4.2 Glucose Oxidase (GOD)
  8.3.5 Historic and Forecasted Market Size By Application
  8.3.5.1 Type 1 Diabetes
  8.3.5.2 Type 2 Diabetes
  8.3.5.3 Gestational Diabetes
  8.3.5.4 Pre-Diabetes
  8.3.6 Historic and Forecasted Market Size By End User
  8.3.6.1 Individuals
  8.3.6.2 Hospitals & Clinics
  8.3.6.3 Others
  8.3.7 Historic and Forecast Market Size by Country
  8.3.7.1 Russia
  8.3.7.2 Bulgaria
  8.3.7.3 The Czech Republic
  8.3.7.4 Hungary
  8.3.7.5 Poland
  8.3.7.6 Romania
  8.3.7.7 Rest of Eastern Europe
 8.4. Western Europe Blood Glucose Test Strip Market
  8.4.1 Key Market Trends, Growth Factors and Opportunities
  8.4.2 Top Key Companies
  8.4.3 Historic and Forecasted Market Size by Segments
  8.4.4 Historic and Forecasted Market Size By Type
  8.4.4.1 Glucose Dehydrogenase (GDH)
  8.4.4.2 Glucose Oxidase (GOD)
  8.4.5 Historic and Forecasted Market Size By Application
  8.4.5.1 Type 1 Diabetes
  8.4.5.2 Type 2 Diabetes
  8.4.5.3 Gestational Diabetes
  8.4.5.4 Pre-Diabetes
  8.4.6 Historic and Forecasted Market Size By End User
  8.4.6.1 Individuals
  8.4.6.2 Hospitals & Clinics
  8.4.6.3 Others
  8.4.7 Historic and Forecast Market Size by Country
  8.4.7.1 Germany
  8.4.7.2 UK
  8.4.7.3 France
  8.4.7.4 The Netherlands
  8.4.7.5 Italy
  8.4.7.6 Spain
  8.4.7.7 Rest of Western Europe
 8.5. Asia Pacific Blood Glucose Test Strip Market
  8.5.1 Key Market Trends, Growth Factors and Opportunities
  8.5.2 Top Key Companies
  8.5.3 Historic and Forecasted Market Size by Segments
  8.5.4 Historic and Forecasted Market Size By Type
  8.5.4.1 Glucose Dehydrogenase (GDH)
  8.5.4.2 Glucose Oxidase (GOD)
  8.5.5 Historic and Forecasted Market Size By Application
  8.5.5.1 Type 1 Diabetes
  8.5.5.2 Type 2 Diabetes
  8.5.5.3 Gestational Diabetes
  8.5.5.4 Pre-Diabetes
  8.5.6 Historic and Forecasted Market Size By End User
  8.5.6.1 Individuals
  8.5.6.2 Hospitals & Clinics
  8.5.6.3 Others
  8.5.7 Historic and Forecast Market Size by Country
  8.5.7.1 China
  8.5.7.2 India
  8.5.7.3 Japan
  8.5.7.4 South Korea
  8.5.7.5 Malaysia
  8.5.7.6 Thailand
  8.5.7.7 Vietnam
  8.5.7.8 The Philippines
  8.5.7.9 Australia
  8.5.7.10 New Zealand
  8.5.7.11 Rest of APAC
 8.6. Middle East & Africa Blood Glucose Test Strip Market
  8.6.1 Key Market Trends, Growth Factors and Opportunities
  8.6.2 Top Key Companies
  8.6.3 Historic and Forecasted Market Size by Segments
  8.6.4 Historic and Forecasted Market Size By Type
  8.6.4.1 Glucose Dehydrogenase (GDH)
  8.6.4.2 Glucose Oxidase (GOD)
  8.6.5 Historic and Forecasted Market Size By Application
  8.6.5.1 Type 1 Diabetes
  8.6.5.2 Type 2 Diabetes
  8.6.5.3 Gestational Diabetes
  8.6.5.4 Pre-Diabetes
  8.6.6 Historic and Forecasted Market Size By End User
  8.6.6.1 Individuals
  8.6.6.2 Hospitals & Clinics
  8.6.6.3 Others
  8.6.7 Historic and Forecast Market Size by Country
  8.6.7.1 Turkiye
  8.6.7.2 Bahrain
  8.6.7.3 Kuwait
  8.6.7.4 Saudi Arabia
  8.6.7.5 Qatar
  8.6.7.6 UAE
  8.6.7.7 Israel
  8.6.7.8 South Africa
 8.7. South America Blood Glucose Test Strip Market
  8.7.1 Key Market Trends, Growth Factors and Opportunities
  8.7.2 Top Key Companies
  8.7.3 Historic and Forecasted Market Size by Segments
  8.7.4 Historic and Forecasted Market Size By Type
  8.7.4.1 Glucose Dehydrogenase (GDH)
  8.7.4.2 Glucose Oxidase (GOD)
  8.7.5 Historic and Forecasted Market Size By Application
  8.7.5.1 Type 1 Diabetes
  8.7.5.2 Type 2 Diabetes
  8.7.5.3 Gestational Diabetes
  8.7.5.4 Pre-Diabetes
  8.7.6 Historic and Forecasted Market Size By End User
  8.7.6.1 Individuals
  8.7.6.2 Hospitals & Clinics
  8.7.6.3 Others
  8.7.7 Historic and Forecast Market Size by Country
  8.7.7.1 Brazil
  8.7.7.2 Argentina
  8.7.7.3 Rest of SA

Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies

Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research